Voluntary Disclosure Announcement on the Release of the Latest Research Results of DZD8586 and DZD6008 at the 2025 American Society of Clinical Oncology (ASCO) Conference

About this update from Dizal (jiangsu) Pharmaceutical Co. Ltd. Class A

Voluntary Disclosure Announcement on the Release of the Latest Research Results of DZD8586 and DZD6008 at the 2025 American Society of Clinical Oncology (ASCO) Conference The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Dizal (jiangsu) Pharmaceutical Co. Ltd. Class A